Obstructive sleep apnea syndrome: natural history, diagnosis, and emerging treatment options.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 3630950)

Published in Nat Sci Sleep on September 28, 2010

Authors

Tarek Gharibeh1, Reena Mehra

Author Affiliations

1: Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Articles cited by this

(truncated to the top 100)

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28

The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med (1993) 35.93

Inflammation in atherosclerosis. Nature (2002) 28.92

Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep (1999) 23.64

Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12

Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet (2005) 17.31

Leptin and the regulation of body weight in mammals. Nature (1998) 14.84

The continuing epidemics of obesity and diabetes in the United States. JAMA (2001) 14.84

Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med (2005) 13.14

Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med (1999) 12.71

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med (2001) 12.29

Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56

Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet (1981) 9.07

Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep (2008) 8.69

Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med (2007) 8.25

Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med (2009) 7.06

Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med (2010) 7.03

Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep (2005) 6.64

Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet (1999) 6.37

The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc (2008) 6.33

TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development (1997) 6.31

Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med (2002) 5.98

Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med (2001) 5.94

Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis (1993) 5.82

Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep (1997) 5.66

Access to diagnosis and treatment of patients with suspected sleep apnea. Am J Respir Crit Care Med (2004) 5.43

Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA (2003) 5.39

The association between sleep apnea and the risk of traffic accidents. Cooperative Group Burgos-Santander. N Engl J Med (1999) 5.33

Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study. Ann Intern Med (2007) 5.29

Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol (2004) 5.26

Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med (2002) 5.15

Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature (1994) 5.00

Surgical correction of anatomic azbnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg (1982) 4.91

Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet (2002) 4.86

Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA (2000) 4.86

Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med (1998) 4.65

Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep (2008) 4.59

Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep (2006) 4.56

Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation (1998) 4.56

Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med (2008) 4.38

Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med (2006) 4.36

Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med (2002) 4.35

Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med (1997) 4.35

Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab (2000) 4.34

Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest (1993) 4.18

Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep (2007) 4.17

Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol (2004) 4.10

Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med (1999) 4.09

Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med (2001) 3.95

A twin study of human obesity. JAMA (1986) 3.92

Contributions of upper airway mechanics and control mechanisms to severity of obstructive apnea. Am J Respir Crit Care Med (2003) 3.80

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J (2004) 3.77

Chemical control stability in patients with obstructive sleep apnea. Am J Respir Crit Care Med (2001) 3.76

Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med (2005) 3.73

Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N Engl J Med (1990) 3.63

Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev (2003) 3.57

Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest (1997) 3.51

Sleep-disordered breathing in community-dwelling elderly. Sleep (1991) 3.46

Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2003) 3.42

Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med (2005) 3.42

Oral appliances for snoring and obstructive sleep apnea: a review. Sleep (2006) 3.28

Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke (2006) 3.28

Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med (2003) 3.26

Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med (2009) 3.24

Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med (2001) 3.19

Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med (2005) 3.19

Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension (1992) 3.14

Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax (2007) 3.07

The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep (1996) 3.03

Socioeconomic differences in children's health: how and why do these relationships change with age? Psychol Bull (2002) 3.01

Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation (2003) 2.99

Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol (2007) 2.99

Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Crit Care Med (1997) 2.99

Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation (2005) 2.99

Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med (1999) 2.98

Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development (1994) 2.98

Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation (2003) 2.98

Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med (2003) 2.96

Association of hypertension and sleep-disordered breathing. Arch Intern Med (2000) 2.95

Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med (2003) 2.95

Upper airway sensation in snoring and obstructive sleep apnea. Am J Respir Crit Care Med (2001) 2.93

Neuromechanical control of upper airway patency during sleep. J Appl Physiol (1985) (2006) 2.93

Do patients with obstructive sleep apnea have thick necks? Am Rev Respir Dis (1990) 2.89

A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med (2002) 2.89

A survey screen for prediction of apnea. Sleep (1995) 2.84

Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med (2005) 2.79

Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med (1999) 2.77

Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol (2002) 2.75

Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med (1999) 2.72

Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation (2003) 2.71

Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med (2004) 2.70

Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med (2001) 2.68

Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet (1994) 2.68

Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med (2005) 2.67

A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest (2001) 2.66

Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med (2007) 2.62

Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med (2005) 2.59

The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep (2001) 2.59

Sleep duration and sleep complaints and risk of myocardial infarction in middle-aged men and women from the general population: the MONICA/KORA Augsburg cohort study. Sleep (2007) 2.59

Articles by these authors

Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med (2012) 8.68

Obstructive sleep apnea devices for out-of-center (OOC) testing: technology evaluation. J Clin Sleep Med (2011) 3.47

The scoring of respiratory events in sleep: reliability and validity. J Clin Sleep Med (2007) 3.07

CPAP versus oxygen in obstructive sleep apnea. N Engl J Med (2014) 2.75

Sleep duration and biomarkers of inflammation. Sleep (2009) 2.73

Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med (2007) 2.38

Reduced renal function and sleep-disordered breathing in community-dwelling elderly men. Sleep Med (2008) 2.26

European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation (2010) 1.90

Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol (2009) 1.78

Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease. Circulation (2013) 1.77

Genome-wide association studies of the PR interval in African Americans. PLoS Genet (2011) 1.53

A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep (2012) 1.37

Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study. Circulation (2008) 1.36

Racial differences in atrial fibrillation prevalence and left atrial size. Am J Med (2010) 1.32

Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep (2008) 1.20

Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project. Circ Cardiovasc Genet (2011) 1.06

Novel loci associated with PR interval in a genome-wide association study of 10 African American cohorts. Circ Cardiovasc Genet (2012) 0.97

Interpreting pulmonary function tests: recognize the pattern, and the diagnosis will follow. Cleve Clin J Med (2003) 0.95

Impact of ancestry and common genetic variants on QT interval in African Americans. Circ Cardiovasc Genet (2012) 0.94

Renal function and sleep-disordered breathing in older men. Nephrol Dial Transplant (2008) 0.93

Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med (2013) 0.86

Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk. J Hypertens (2014) 0.86

A measure of ventilatory variability at wake-sleep transition predicts sleep apnea severity. Chest (2008) 0.83

Sleep-disordered breathing and urinary albumin excretion in older men. Sleep Breath (2010) 0.82

Variations in physician interpretation of overnight pulse oximetry monitoring. Chest (2007) 0.81

Association between obstructive sleep apnea severity and endothelial dysfunction in an increased background of cardiovascular burden. J Sleep Res (2013) 0.80

Arrhythmia risk associated with sleep disordered breathing in chronic heart failure. Curr Heart Fail Rep (2014) 0.80

Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium. Atherosclerosis (2012) 0.79

Effect of continuous positive airway pressure on an atrial arrhythmia in a patient with mild obstructive sleep apnea. J Clin Sleep Med (2011) 0.78

Sleep technologist performance: a call for standardization and performance feedback. Sleep Breath (2009) 0.76

A man with abnormal sleep behavior. J Clin Sleep Med (2007) 0.75

The Weighty Issue of Obesity Management in Sleep Apnea. Chest (2015) 0.75

Diagnosing obstructive sleep apnea in the setting of comorbid pulmonary disease. Chest (2009) 0.75

A Paradigm Shift in the Treatment of Central Sleep Apnea in Heart Failure. Chest (2015) 0.75

Pulmonary medicine and critical care. J Am Geriatr Soc (2009) 0.75

Failing sleep? Beware of frailty or death. Sleep Med (2012) 0.75

A 52-year-old man with excessive daytime sleepiness. Cleve Clin J Med (2002) 0.75

Impact of the COVID-19 pandemic on healthcare workers risk of infection and outcomes in a large, integrated health system. Res Sq (2020) 0.75

Dissociation of Objective and Subjective Daytime Sleepiness and Biomarkers of Systemic Inflammation in Sleep-Disordered Breathing and Systolic Heart Failure. J Clin Sleep Med (2017) 0.75

Impact of Sleep-Disordered Breathing Treatment on Quality of Life Measures in a Large Clinic-Based Cohort. J Clin Sleep Med (2017) 0.75

Treating obstructive sleep apnea with positive pressure therapy. Curr Treat Options Neurol (2011) 0.75

Sleep Apnea and Nocturnal Cardiac Arrhythmia: Understanding Differences Across Ethnicity. J Clin Sleep Med (2017) 0.75

Changing landscape and disease-specific considerations of therapeutic bronchoscopy in clinical trials. J Bronchology Interv Pulmonol (2014) 0.75